Switching the targeting pathways of a therapeutic antibody by nanodesign. - Wikidata - awgldk - TriplyDB

Switching the targeting pathways of a therapeutic antibody by nanodesign.

Switching the targeting pathways of a therapeutic antibody by nanodesign.

http://www.wikidata.org/entity/Q35882643

about

Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells.Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67 Design and applications of gold nanoparticle conjugates by exploiting biomolecule-gold nanoparticle interactions.Engineered nanoparticles: thrombotic events in cancer.Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles.Stabilization of α-helices by the self-assembly of macrocyclic peptides on the surface of gold nanoparticles for molecular recognition.Bioorthogonal chemistry for selective recognition, separation and killing bacteria over mammalian cells.Fast Targeting and Cancer Cell Uptake of Luminescent Antibody-Nanozeolite Bioconjugates.Internalization studies on zeolite nanoparticles using human cells

P2860

Q33804603-D9EA7297-11C1-4727-997B-3303285ABAF5 Q35942437-66022D0D-F5AD-490E-BDDD-1819F533B9D9 Q36929055-6936337D-1255-46A2-83F3-E7EC3F789DA5 Q36953748-E6DBD367-3521-4443-BB45-8BF107A17D23 Q38083022-F2F75FDF-5E86-4F19-94DB-750C8F7CCE78 Q38262939-4557FE4A-C7D3-4523-936B-73DE56C1CA3A Q39119319-53AB94C7-3182-4275-996E-991C447BF441 Q39256568-35AF1D34-210F-4E23-B8A0-E9E13CA73400 Q45850873-478D6B3D-E052-4D0C-862E-DE2E18FAEEEC Q50886875-1011983D-2339-426C-9731-948B96ECB867 Q51205963-60C79B3F-88CB-4151-91C8-99504A1CF8AB Q58356969-EDC6CCBB-3FD7-41CE-B696-0B8583795E8F

P2860

Switching the targeting pathways of a therapeutic antibody by nanodesign.

http://www.wikidata.org/entity/Q35882643

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Switching the targeting pathways of a therapeutic antibody by nanodesign.

@ast

Switching the targeting pathways of a therapeutic antibody by nanodesign.

@en

type

label

Switching the targeting pathways of a therapeutic antibody by nanodesign.

@ast

Switching the targeting pathways of a therapeutic antibody by nanodesign.

@en

prefLabel

Switching the targeting pathways of a therapeutic antibody by nanodesign.

@ast

Switching the targeting pathways of a therapeutic antibody by nanodesign.

@en

P1433

Q35882643-DC8E31E6-DBC1-47E0-A877-EA67DDB41CA5

P1476

Q35882643-CE22A27F-5537-457C-9A63-6A3DD8B7EBB2

P2093

Q35882643-027CDE66-2D0B-4659-ADFB-8C6544F96970

Q35882643-0A500CF6-058C-4416-8111-683726CF5D85

Q35882643-909A6AC2-448A-4ABF-B1EB-571DE0438B44

Q35882643-91DA337F-B42C-4D72-979F-869B3DFA1C46

Q35882643-BE443885-A7AA-466D-9A01-7B3EC8F4AA0A

Q35882643-C7337180-FB59-4E79-9121-27A2182EA027

P2860

Q35882643-48FBA879-E7C7-4C8D-8E13-0CDF87789FB6

Q35882643-4C8C9278-D8E0-4DB6-AD3D-84FC2C3504F4

Q35882643-5D8A4C61-074B-455E-802F-DEA5D0BE1917

Q35882643-750D1008-171E-47A1-A7E5-5696152E80C2

Q35882643-755D2F36-C82A-4B54-A5AA-BE2B8322C029

Q35882643-88AFF1DA-8E6F-4FFB-879B-84F09DEC0CA9

Q35882643-8D315961-961E-44EB-8356-174DA2E06B16

Q35882643-A1C47E77-17CB-453F-AC5B-8BA779401F59

Q35882643-A339BDE7-502C-4790-83A0-F906790810EA

Q35882643-AE09A624-DA4C-4368-8012-17000F8763B0

P304

Q35882643-24939B50-3E3D-4C07-BECC-604894946C78

P31

Q35882643-F9A20EAC-2291-4873-9802-E24A37545D80

P356

Q35882643-91C5A464-A2C4-4E69-9891-E8F5AF5EF8C5

P407

Q35882643-258007DA-49C4-439B-A7A0-4A922052BE6D

P433

Q35882643-8C00349B-2E14-4EAB-B551-1980C92226B0

P478

Q35882643-DD72976E-60BF-4631-87A5-47445B50E97C

P577

Q35882643-4C1F588A-7664-476E-AAAA-233B0643AA7C

P5875

Q35882643-CFCB5A3B-C7BF-48DE-A887-40419EEAC299

P698

Q35882643-94A03BA1-4916-4FF7-9B0D-31C384629F57

P932

Q35882643-48FFD4F9-1F66-4AFF-8891-42AF4A3FA08E

P356

P1433

Angewandte Chemie International Edition

P1476

Switching the targeting pathways of a therapeutic antibody by nanodesign.

@en

P2093

J David Robertson

http://www.w3.org/2001/XMLSchema#string

Priyabrata Mukherjee

http://www.w3.org/2001/XMLSchema#string

Raman Deep Singh

http://www.w3.org/2001/XMLSchema#string

Resham Bhattacharya

http://www.w3.org/2001/XMLSchema#string

Richard Pagano

http://www.w3.org/2001/XMLSchema#string

Sanjib Bhattacharyya

http://www.w3.org/2001/XMLSchema#string

P2860

Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo

Immunological properties of engineered nanomaterials

The multiple faces of caveolae

Pathways of clathrin-independent endocytosis

Cdc42 is not essential for filopodium formation, directed migration, cell polarization, and mitosis in fibroblastoid cells

Function of Rho family proteins in actin dynamics during phagocytosis and engulfment.

Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis.

Distinct mechanisms of clathrin-independent endocytosis have unique sphingolipid requirements.

Drivers of biodiagnostic development.

Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship.

P304

1563-1567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANIE.201105432

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51847363

http://www.w3.org/2001/XMLSchema#string

P698

22135077

http://www.w3.org/2001/XMLSchema#string

P932

3324088

http://www.w3.org/2001/XMLSchema#string